Startups and university-backed projects, join us to learn about the application process and eligibility requirements to be part of the first cohort of I-CREATE.
Are you working on groundbreaking diagnostics or medical device countermeasures that address public health? I-CREATE is part of a global network of accelerator hubs that provide product development funding, accelerator services, and access to expertise for innovators developing health security solutions.
Startups and university-backed projects worldwide can apply for non-dilutive funding ranging from $50K to $200K. This funding supports the development, evaluation, or validation of innovative solutions aligned with BARDA’s mission to enhance pandemic preparedness and health security. I-CREATE supports the development and acceleration of novel diagnostics and medical devices to detect, prevent, or respond to medical consequences that result from health security threats.
Stephanie Chan, PhD is a seasoned expert in the medical device and diagnostics sectors with over a decade of experience within startup ecosystems, venture capital, and product development. Having worked in cross-functional roles across biotechnology, she brings comprehensive expertise in research and development, clinical validation, manufacturing, quality assurance, and regulatory affairs—making her an invaluable resource for diagnostic development. With firsthand experience from the startup perspective, Stephanie offers innovative solutions and strategic recommendations to emerging companies in the biotech and diagnostics industries. Passionate about guiding startups through the complexities of commercialization, she is dedicated to advancing the next generation of diagnostic technologies.
Wednesday, July 23, 2025
10:00 AM - 11:00 AM PT
Join us for a webinar. Register Here